학술논문
Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
Document Type
Short Survey
Author
Source
In Gastroenterology July 2023 165(1):286-288
Subject
Language
ISSN
0016-5085